Assembling Surfactants-Mucoadhesive Polymer Nanomicelles (ASMP-Nano) for Ocular Delivery of Cyclosporine-A

The physiological protective mechanisms of the eye reduce the bioavailability of topically administered drugs above all for those with high molecular weight and /or lipophilic characteristics, such as Cyclosporine A (CyA). The combined strategy based on the association of nanomicelles and mucoadhesi...

Full description

Saved in:
Bibliographic Details
Main Authors: Eleonora Terreni (Author), Patrizia Chetoni (Author), Silvia Tampucci (Author), Susi Burgalassi (Author), Ali Athab Al-kinani (Author), Raid G. Alany (Author), Daniela Monti (Author)
Format: Book
Published: MDPI AG, 2020-03-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_1ccd38b3ffd34676b81c1aa0af49ce20
042 |a dc 
100 1 0 |a Eleonora Terreni  |e author 
700 1 0 |a Patrizia Chetoni  |e author 
700 1 0 |a Silvia Tampucci  |e author 
700 1 0 |a Susi Burgalassi  |e author 
700 1 0 |a Ali Athab Al-kinani  |e author 
700 1 0 |a Raid G. Alany  |e author 
700 1 0 |a Daniela Monti  |e author 
245 0 0 |a Assembling Surfactants-Mucoadhesive Polymer Nanomicelles (ASMP-Nano) for Ocular Delivery of Cyclosporine-A 
260 |b MDPI AG,   |c 2020-03-01T00:00:00Z. 
500 |a 1999-4923 
500 |a 10.3390/pharmaceutics12030253 
520 |a The physiological protective mechanisms of the eye reduce the bioavailability of topically administered drugs above all for those with high molecular weight and /or lipophilic characteristics, such as Cyclosporine A (CyA). The combined strategy based on the association of nanomicelles and mucoadhesive polymer seems promising since a limited number of commercial products containing CyA have been recently approved. The scope of this investigation was the design of Assembling Surfactants-Mucoadhesive Polymer Nanomicelles (ASMP-Nano), based on a binary system of two surfactants in combination with hyaluronic acid, and their biopharmaceutical evaluation. The optimisation of the ASMP-Nano in term of the amount of surfactants, CyA-loading and size determined the selection of the clear and stable Nano1HAB-CyA formulation containing 0.105% <i>w</i>/<i>w</i> CyA loaded-nanomicelles with a size of 14.41 nm. The nanostructured system had a protective effect towards epithelial corneal cells with a cell viability of more than 80%. It interacted with cellular barriers favouring the uptake and the accumulation of CyA into the cells as evidenced by fluorescent probe distribution, by hindering CyA permeation through reconstituted corneal epithelial tissue. In pharmacokinetics study on rabbits, the nanomicellar carrier prolonged the CyA retention time in the precorneal area mainly in presence of hyaluronic acid (HA), a mucoadhesive polymer. 
546 |a EN 
690 |a nanomicelles 
690 |a ocular pharmacokinetic 
690 |a rabbits 
690 |a hyaluronic acid 
690 |a vitamin e-tpgs 
690 |a cyclosporine a 
690 |a reconstituted corneal tissue 
690 |a Pharmacy and materia medica 
690 |a RS1-441 
655 7 |a article  |2 local 
786 0 |n Pharmaceutics, Vol 12, Iss 3, p 253 (2020) 
787 0 |n https://www.mdpi.com/1999-4923/12/3/253 
787 0 |n https://doaj.org/toc/1999-4923 
856 4 1 |u https://doaj.org/article/1ccd38b3ffd34676b81c1aa0af49ce20  |z Connect to this object online.